Skip to content

Steroid increases lean muscle mass in HIV-positive men, but has side-effects

Graves' disease may be a risk for patients starting ART with a low CD4 cell count who then have good immune restoratation

MSF calls for rapid registration of heat-stable Kaletra in low-income countries

Treatment interruption arm of DART study halted

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

US launches drive to find better HIV treatments for children in poorest countries

The high cost of non-antiretroviral medicines used by people with AIDS in Côte d’Ivoire

Co-packaged AZT/3TC/efavirenz regimen approved for use in PEPFAR programmes